Markets
MA Stock Indexes
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Local Stocks
Emergent Biosolutions (NY: EBS)
14.22 USD  -0.12 (-0.84%)
Streaming Delayed Price  /  Updated: 3:12 PM EDT, May 21, 2013  /  Add to My Watchlist      
View: Quote News Research
Press releases about Emergent Biosolutions
 
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Emergent BioSolutions Reports Financial Results for Third Quarter 2007
November 02, 2007
-- Raises full year 2007 revenue guidance to reflect annual growth of 16 to 18 percent -- On track to deliver up to 6 million doses under new contract with HHS by year end Read More
from Business Wire News Releases
Emergent BioSolutions to Present at November Investor Conferences
October 29, 2007
from Business Wire News Releases
Baker Hughes Announces Third Quarter Results
October 26, 2007
from PR Newswire
Baker Hughes Declares Regular Quarterly Dividend
October 25, 2007
from PR Newswire
Emergent BioSolutions to Release Third Quarter 2007 Financial Results on November 2, 2007; Management Will Conduct a Conference Call to Discuss Results as Well as Provide an Update on Business Develop
October 22, 2007
from Business Wire News Releases
Emergent BioSolutions Announces Dr. Stephen Lockhart Joins Company to Lead Commercial Product Development Subsidiary
October 18, 2007
Dr. Lockhart Brings Top-Tier Pharma Leadership to Development of Company's Commercial Product Portfolio Read More
from Business Wire News Releases
Emergent BioSolutions' Typhoid Vaccine Candidate Achieves Endpoints in Phase II Clinical Study
October 10, 2007
Vaccine Well Tolerated and Immunogenic in Double-Blind, Placebo-Controlled Study in Pediatric Population Read More
from Business Wire News Releases
Emergent BioSolutions Announces the Appointment of Denise Landry as Senior Vice President, Quality
October 09, 2007
from Business Wire News Releases
Baker Hughes Announces September 2007 Rig Counts
October 05, 2007
from PR Newswire
Emergent BioSolutions to Present at BIO InvestorForum 2007
October 03, 2007
from Business Wire News Releases
Emergent BioSolutions Completes First Delivery of BioThrax(R) (Anthrax Vaccine Adsorbed) to The Department of Health and Human Services under New Contract
October 02, 2007
Company Estimates 3Q 2007 BioThrax Revenues of Approximately $42 Million Read More
from Business Wire News Releases
Emergent BioSolutions Receives Development Contract from NIAID/BARDA to Fund Continued Development of Anthrax Therapeutic
September 27, 2007
$9.5 Million Development Contract to Fund Non-Clinical and Clinical Studies of Anthrax Immune Globulin (AIG) over Next 24 Months Read More
from Business Wire News Releases
Emergent BioSolutions Signs $448 Million Three Year Contract with Department of Health and Human Services
September 26, 2007
from Business Wire News Releases
Baker Hughes Announces Conference Call
September 21, 2007
from PR Newswire
Baker Hughes Announces August 2007 Rig Counts
September 10, 2007
from PR Newswire
Emergent BioSolutions to Present at the Thomas Weisel Partners Healthcare Conference 2007
August 20, 2007
from Business Wire News Releases
Baker Hughes Announces July 2007 Rig Counts
August 07, 2007
U.S. Workover Rig Count To Be Discontinued Read More
from PR Newswire
Emergent BioSolutions Reports Financial Results for Second Quarter 2007
August 06, 2007
-- Year over Year Growth in Product Revenues of $14.3 Million to $22.5 Million Read More
from Business Wire News Releases
Baker Hughes Announces Second Quarter Results
July 27, 2007
from PR Newswire
Baker Hughes Declares Regular Quarterly Dividend
July 26, 2007
from PR Newswire
Emergent BioSolutions to Release Second Quarter 2007 Financial Results on August 6, 2007; Management Will Conduct a Conference Call to Discuss Results as Well as Provide an Update on Business Developm
July 20, 2007
from Business Wire News Releases
Baker Hughes Announces Second Quarter 2007 Preliminary Results
July 13, 2007
from PR Newswire
Emergent BioSolutions and HSBC Sign $30 Million Loan to Support Manufacturing Expansion Program
July 03, 2007
Loan Replaces Existing $15 Million HSBC Credit Facility Read More
from Business Wire News Releases
Emergent BioSolutions Anticipates 2nd Quarter BioThrax Revenues of Approximately $20 Million Based on Accelerated Delivery to Department of Defense
June 27, 2007
Company Preparing Response to DoD Request for Proposal for Delivery of Up to 14 Million Additional Doses of BioThrax Read More
from Business Wire News Releases
Emergent BioSolutions to Present at the Jefferies & Company Healthcare Conference
June 20, 2007
from Business Wire News Releases
Emergent BioSolutions Announces Expansion of Board of Directors and Appointment of Dr. Sue Bailey to the Company's Board of Directors
June 15, 2007
Dr. Bailey Brings DoD and Media Relations Expertise to the Company's Board Read More
from Business Wire News Releases
Baker Hughes Announces Conference Call
June 14, 2007
from PR Newswire
Emergent BioSolutions Announces Results from Annual Meeting of Stockholders
June 14, 2007
from Business Wire News Releases
Emergent BioSolutions to Hold Annual Meeting of Stockholders
June 11, 2007
from Business Wire News Releases
Baker Hughes Announces May 2007 Rig Counts
June 07, 2007
from PR Newswire
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here